HEPION PHARMACEUTICALS, INC. Current Portion of Long-Term Debt
HEPION PHARMACEUTICALS, INC. (HEPA) had Current Portion of Long-Term Debt of $176.59 thousand as of 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2021-05-14
- 2021-03-31: Long-term Debt, Current Maturities $176.59K.
- 2020-12-31: Long-term Debt, Current Maturities $0.00.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2021-03-31 | $176.59K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $0.00 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |